177 related articles for article (PubMed ID: 29678521)
1. Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions.
Takaoka N; Sanoh S; Okuda K; Kotake Y; Sugahara G; Yanagi A; Ishida Y; Tateno C; Tayama Y; Sugihara K; Kitamura S; Kurosaki M; Terao M; Garattini E; Ohta S
Biochem Pharmacol; 2018 Aug; 154():28-38. PubMed ID: 29678521
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the role of mammalian aldehyde oxidases in the metabolism of drugs and xenobiotics.
Romão MJ; Coelho C; Santos-Silva T; Foti A; Terao M; Garattini E; Leimkühler S
Curr Opin Chem Biol; 2017 Apr; 37():39-47. PubMed ID: 28126656
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase.
Coelho C; Foti A; Hartmann T; Santos-Silva T; Leimkühler S; Romão MJ
Nat Chem Biol; 2015 Oct; 11(10):779-83. PubMed ID: 26322824
[TBL] [Abstract][Full Text] [Related]
4. Involvement of aldehyde oxidase in the metabolism of aromatic and aliphatic aldehyde-odorants in the mouse olfactory epithelium.
Takaoka N; Sanoh S; Ohta S; Esmaeeli M; Leimkühler S; Kurosaki M; Terao M; Garattini E; Kotake Y
Arch Biochem Biophys; 2022 Jan; 715():109099. PubMed ID: 34856193
[TBL] [Abstract][Full Text] [Related]
5. Effect of commonly used organic solvents on aldehyde oxidase-mediated vanillin, phthalazine and methotrexate oxidation in human, rat and mouse liver subcellular fractions.
Behera D; Pattem R; Gudi G
Xenobiotica; 2014 Aug; 44(8):722-33. PubMed ID: 24533630
[TBL] [Abstract][Full Text] [Related]
6. Effects of Phenothiazines on Aldehyde Oxidase Activity Towards Aldehydes and N-Heterocycles: an In Vitro and In Silico Study.
Deris-Abdolahpour F; Abdolalipouran-Sadegh L; Dastmalchi S; Hamzeh-Mivehroud M; Zarei O; Dehgan G; Rashidi MR
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):275-286. PubMed ID: 30382490
[TBL] [Abstract][Full Text] [Related]
7. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
[TBL] [Abstract][Full Text] [Related]
8. A rapid and sensitive fluorometric method for determination of aldehyde oxidase activity.
Apenova N; Peng H; Hecker M; Brinkmann M
Toxicol Appl Pharmacol; 2018 Feb; 341():30-37. PubMed ID: 29329804
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the study of aldehyde oxidases].
Mi JQ; Li Y
Yao Xue Xue Bao; 2014 May; 49(5):582-9. PubMed ID: 25151725
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of mammalian aldehyde oxidases.
Terao M; Romão MJ; Leimkühler S; Bolis M; Fratelli M; Coelho C; Santos-Silva T; Garattini E
Arch Toxicol; 2016 Apr; 90(4):753-80. PubMed ID: 26920149
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
[TBL] [Abstract][Full Text] [Related]
12. Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy.
Sanoh S; Tayama Y; Sugihara K; Kitamura S; Ohta S
Drug Metab Pharmacokinet; 2015 Feb; 30(1):52-63. PubMed ID: 25760530
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.
Choughule KV; Barr JT; Jones JP
Drug Metab Dispos; 2013 Oct; 41(10):1852-8. PubMed ID: 23918666
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic evaluation of substrate inhibition kinetics observed from aldehyde oxidase-catalyzed reactions.
Wang SW; Abdul-Hadi K; Cohen L; Xia CQ
Drug Metab Lett; 2013 Mar; 7(1):2-14. PubMed ID: 24151826
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of human liver aldehyde oxidase by raloxifene.
Obach RS
Drug Metab Dispos; 2004 Jan; 32(1):89-97. PubMed ID: 14709625
[TBL] [Abstract][Full Text] [Related]
16. Human liver aldehyde oxidase: inhibition by 239 drugs.
Obach RS; Huynh P; Allen MC; Beedham C
J Clin Pharmacol; 2004 Jan; 44(1):7-19. PubMed ID: 14681337
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues.
Chen S; Austin-Muttitt K; Zhang LH; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2019 Oct; 371(1):75-86. PubMed ID: 31289113
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon.
Beedham C; Critchley DJ; Rance DJ
Arch Biochem Biophys; 1995 Jun; 319(2):481-90. PubMed ID: 7786031
[TBL] [Abstract][Full Text] [Related]
19. The first mammalian aldehyde oxidase crystal structure: insights into substrate specificity.
Coelho C; Mahro M; Trincão J; Carvalho AT; Ramos MJ; Terao M; Garattini E; Leimkühler S; Romão MJ
J Biol Chem; 2012 Nov; 287(48):40690-702. PubMed ID: 23019336
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde oxidase importance in vivo in xenobiotic metabolism: imidacloprid nitroreduction in mice.
Swenson TL; Casida JE
Toxicol Sci; 2013 May; 133(1):22-8. PubMed ID: 23462233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
